
浏览全部资源
扫码关注微信
1. 上海中医药大学附属龙华医院药学部
2. 六安市中医医院药剂科
3. 苏州市中医医院药剂科
纸质出版日期:2021,
扫 描 看 全 文
[1]周桂,王坤,徐俐伟,周昕.2019—2020年上海中医药大学附属龙华医院首乌藤、何首乌和制何首乌临床应用分析[J].中国医院用药评价与分析,2021,21(02):227-231+236.
ZHOU Gui, WANG Kun, XU Liwei, et al. Clinical Application of Polygoni Multiflori Caulis,Polygoni Multiflori Radix and Polygoni Multiflori Radix Preparata in Longhua Hospital Shanghai University of Traditional Chinese Medicine from 2019 to 2020[J]. 2021,21(2):227-231.
[1]周桂,王坤,徐俐伟,周昕.2019—2020年上海中医药大学附属龙华医院首乌藤、何首乌和制何首乌临床应用分析[J].中国医院用药评价与分析,2021,21(02):227-231+236. DOI: 10.14009/j.issn.1672-2124.2021.02.024.
ZHOU Gui, WANG Kun, XU Liwei, et al. Clinical Application of Polygoni Multiflori Caulis,Polygoni Multiflori Radix and Polygoni Multiflori Radix Preparata in Longhua Hospital Shanghai University of Traditional Chinese Medicine from 2019 to 2020[J]. 2021,21(2):227-231. DOI: 10.14009/j.issn.1672-2124.2021.02.024.
目的:了解上海中医药大学附属龙华医院(以下简称"我院")门诊及住院病房首乌藤、何首乌和制何首乌的使用情况
促进合理用药
提高用药安全性。方法:利用我院HIS系统
抽取2019—2020年门诊、住院患者处方
共207 398张。运用我院自行研发的处方分析系统PA软件(软件登记号:2017SR012498)
对首乌藤、何首乌和制何首乌的使用人群、适应证、使用科室、用法用量以及不良反应发生率等进行专项点评
并对点评结果进行统计分析
判断用药的合理性。结果:首乌藤使用最多
其次为制何首乌
何首乌使用最少;在门诊
首乌藤的处方数为163 327张
约为制何首乌处方数(36 278张)的4.5倍
约为何首乌处方数(121张)的1 349倍;在住院病房
首乌藤的处方数为6 251张
约为制何首乌处方数(1 421张)的4.4倍。首乌藤和制何首乌多用于肿瘤科
与两者的功效相符合;何首乌多用于专家门诊和风湿科
反应出临床使用何首乌比较谨慎
与其功效也相符合。首乌藤、何首乌和制何首乌均存在不同程度的超剂量使用现象。门诊和住院病房的用药情况基本一致。首乌藤、何首乌和制何首乌致肝损伤发生率均<1%
属于偶见不良反应。结论:在注意好辨证论治、掌握用量、注意配伍药物、不长时间使用、不滥用和不用于有肝病史患者的情况下
可以较安全地使用蓼科植物何首乌的根和藤。
OBJECTIVE: To investigate the application status of Polygoni Multiflori Caulis
Polygoni Multiflori Radix and Polygoni Multiflori Radix Preparata in outpatient and inpatient department of Longhua Hospital Shanghai University of Traditional Chinese Medicine( hereinafter referred to as "our hospital") from 2019 to 2020
so as to promote the rational drug use and improve the drug safety.METHODS: A total of 207 398 prescriptions for outpatients and inpatients from 2019 to 2020 were extracted by HIS system of our hospital. The prescription analysis system PA software( software registration number: 2017 SR012498) developed by our hospital was used to perform prescription review on the users
indications
departments
usage and dosage and the incidence of adverse drug reactions of Polygoni Multiflori Caulis
Polygoni Multiflori Radix and Polygoni Multiflori Radix Preparata. Evaluation results were statistically analyzed to judge the rationality of medication. RESULTS: The use of Polygoni Multiflori Caulis was the most
followed by Polygoni Multiflori Radix Preparata and Polygoni Multiflori Radix. In the outpatient department
there were 163 327 prescriptions of Polygoni Multiflori Caulis
which was about 4. 5 times of the prescriptions of Polygoni Multiflori Radix Preparata( 36 278 prescriptions)
and about 1 349 times of the prescriptions of Polygoni Multiflori Radix( 121 prescriptions).In the inpatient ward
there were 6 251 prescriptions of Polygoni Multiflori Caulis
which was about 4. 4 times of the prescriptions of Polygoni Multiflori Radix Preparata( 1 421 prescriptions). Polygoni Multiflori Caulis and Polygoni Multiflori Radix Preparata were mostly used in oncology department
which was consistent with the efficacy of both. Polygoni Multiflori Radix was mostly used in specialist clinics and rheumatology department
which reflected that the clinical use of Polygoni Multiflori Radix was more cautious and was consistent with its efficacy. Polygoni Multiflori Caulis
Polygoni Multiflori Radix and Polygoni Multiflori Radix Preparata all had different degrees of overdose use. The drug use in outpatient and inpatient department was basically the same. The incidence of liver injury induced by Polygoni Multiflori Caulis
Polygoni Multiflori Radix and Polygoni Multiflori Radix Preparata were all less than 1%
which was the occasional adverse drug reaction.CONCLUSIONS: The root and vine of Polygonum multiflorum Thunb.can be safely used under the conditions of paying attention to syndrome differentiation and treatment
mastering the dosage
compatibility of drugs
not using for a long time
no abuse and not using for patients with liver disease history.
首乌藤何首乌制何首乌临床分析
Polygoni Multiflori CaulisPolygoni Multiflori RadixPolygoni Multiflori Radix PreparataClinical analysis
0
浏览量
83
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621